Moreover, Sundaresan et al. (2016) results strongly suggest that ursolic acid and rosiglitazone combination activates IRS‐PI3‐kinase‐Akt‐dependent signaling pathways to induce GLUT‐4 translocation and increases the expression of insulin receptor to improve glucose intolerance. Here, AKT1 is linked to Glucose intolerance.